These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30942281)

  • 1. Specific characteristics of the medical history of swallowing before and after application of botulinum toxin in patients with cervical dystonia.
    Vilanova TFDD; Borges V; Ferraz HB
    Clinics (Sao Paulo); 2019 Apr; 74():e776. PubMed ID: 30942281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin type B in the management of dystonia non-responsive to botulinum toxin type A].
    Cardoso F
    Arq Neuropsiquiatr; 2003 Sep; 61(3A):607-10. PubMed ID: 14513166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence-based medicine in botulinum toxin therapy for cervical dystonia.
    Ceballos-Baumann AO
    J Neurol; 2001 Apr; 248 Suppl 1():14-20. PubMed ID: 11357233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast voluntary neck movements in patients with cervical dystonia: a kinematic study before and after therapy with botulinum toxin type A.
    Gregori B; Agostino R; Bologna M; Dinapoli L; Colosimo C; Accornero N; Berardelli A
    Clin Neurophysiol; 2008 Feb; 119(2):273-80. PubMed ID: 18063411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Indications and management of botulinum toxin].
    Singer C
    Rev Neurol; 1999 Jul 16-31; 29(2):157-62. PubMed ID: 10528331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label study of botulinum toxin A for treatment of tardive dystonia.
    Tarsy D; Kaufman D; Sethi KD; Rivner MH; Molho E; Factor S
    Clin Neuropharmacol; 1997 Feb; 20(1):90-3. PubMed ID: 9037579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injection for the treatment of upper esophageal sphincter dysfunction.
    Kelly EA; Koszewski IJ; Jaradeh SS; Merati AL; Blumin JH; Bock JM
    Ann Otol Rhinol Laryngol; 2013 Feb; 122(2):100-8. PubMed ID: 23534124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Efficacy of botulinum toxin type A against cervical dystonia and muscular hypertonia in persons with severe motor and intellectual disabilities with respiratory problems and/or dysphagia].
    Yokoyama M; Honda M; Okoshi Y; Masuyama T; Iwasaki Y; Arima M
    No To Hattatsu; 2011 Jul; 43(4):273-6. PubMed ID: 21800689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Oropharyngeal Dysphagia Before and After Botulinum Toxin Injection in Cervical Dystonia.
    Silbergleit AK; Isabell K; Turnbull J; Patel N; Boettcher E; Konnai R; Collins D; Sidiropoulos C; Schultz L
    Dysphagia; 2023 Oct; 38(5):1421-1429. PubMed ID: 37071189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor.
    Estes C; Sadoughi B; Coleman R; Sarva H; Mauer E; Sulica L
    Laryngoscope; 2018 Feb; 128(2):437-446. PubMed ID: 28988441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin A for patients with orofacial dystonia: prospective, observational, single-centre study.
    Ruiz-de-León-Hernández G; Díaz-Sánchez RM; Torres-Lagares D; Hernández-Pacheco E; González-Martín M; Serrera-Figallo MA
    Int J Oral Maxillofac Surg; 2018 Mar; 47(3):386-391. PubMed ID: 29208327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up.
    Tan EK; Jankovic J
    Neurology; 1999 Dec; 53(9):2102-7. PubMed ID: 10599789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of botulinum toxin type A in treatment of different forms of focal dystonias in the Serbian population: experience of the Botulinum Toxin Outpatients Department.
    Tomić A; Vujović B; Svetel M; Misković ND; Petrović I; Pekmezović T; Kostić VS
    Vojnosanit Pregl; 2015 Dec; 72(12):1069-73. PubMed ID: 26898029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of effect of botulinum toxin type A in adult patients with cervical dystonia: a retrospective chart review.
    Brashear A; Watts MW; Marchetti A; Magar R; Lau H; Wang L
    Clin Ther; 2000 Dec; 22(12):1516-24. PubMed ID: 11192142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing.
    Lowe NJ; Yamauchi PS; Lask GP; Patnaik R; Moore D
    J Cosmet Laser Ther; 2002 Mar; 4(1):15-8. PubMed ID: 12079632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Botulinum toxin for the treatment of major depressive disorder].
    Hawlik AE; Freudenmann RW; Pinkhardt EH; Schönfeldt-Lecuona CJ; Gahr M
    Fortschr Neurol Psychiatr; 2014 Feb; 82(2):93-9. PubMed ID: 24519192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tremor in Idiopathic Cervical Dystonia - Possible Implications for Botulinum Toxin Treatment Considering the Col-Cap Classification.
    Pandey S; Kreisler A; Drużdż A; Biering-Sørensen B; Sławek J; Tatu L; Jost WH
    Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():13. PubMed ID: 32775027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Jaw-opening oromandibular dystonia secondary to Wilson's disease treated with botulinum toxin type A.
    Teive HA; Klüppel LE; Munhoz RP; Becker N; Müller PR; Werneck LC
    Arq Neuropsiquiatr; 2012 Jun; 70(6):407-9. PubMed ID: 22699536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The central action of botulinum toxin type A assessed by brain auditory and somatosensory evoked potentials].
    Sławek J; Recławowicz D
    Neurol Neurochir Pol; 2004; 38(2):93-9. PubMed ID: 15307601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.